CSL Of Australia Faces U.S. University In Plasma Class-Action Suit
This article was originally published in PharmAsia News
Executive Summary
Australia's CSL faces an additional foe in an expanding blood-plasma class-action suit, this one a U.S. university claiming damages. The University of Utah joined the class-action suit in a U.S. district court, seeking $10 million from CSL, its CSL Behring unit and Baxter International, CSL's main competitor in the United States. The university is the first educational institution to join the suit filed by several U.S. hospitals claiming the company conspired with other plasma companies to rig markets and plasma supplies. (Click here for more